from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1331/-

LFCtreatmentdescriptionclass of inhibitor

-1.159

Amikacinug/mL Amikacintranslation

-1.139

Cap5-10ug/mL Capreomycintranslation

-1.757

Rox10-50 ug/mL Roxithromycintranslation

-0.620

SM2-5 ug/mL Streptomycintranslation

-1.120

Tet5-10 ug/mL Tetracyclinetranslation

0.457

Rif0.2-5ug/mL Rifampicintranscription

-0.113

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.605

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.862

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.194

CPZ10-50 ug/mL Chlorpromazinerespiration

0.093

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.579

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.729

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.578

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.532

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.101

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.202

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.491

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.498

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.227

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.325

KCN5-20 ug/mL Potassium cyaniderespiration

0.464

NaN30.2-2 mM Sodium aziderespiration

-1.158

Nigericin50 uM Nigericinrespiration

0.843

TRC10-150 ug/mL Triclosanrespiration

1.168

TRZ10-25 ug/mL Thioridazinerespiration

-2.277

Valinomycin0.5-10 uM Valinomycinrespiration

-0.810

ZnSO42 mM ZnSO4respiration

-0.146

menadione6-10 ug/mL Menadionerespiration

-0.564

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.906

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.948

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.120

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.282

NRP_1Non-replicating persistence stage 1dosRassociated

0.013

Amp0.2mg/mL AmpicillincellWall

-0.638

Cephalexin20-100 ug/mL CephalexincellWall

-0.663

Cerulenin0.32-5 ug/mL CerulenincellWall

0.921

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.328

EMB10-20 ug/mL EthambutolcellWall

0.064

Eta12-40 ug/mL EthionamidecellWall

0.222

INH0.2-0.4 ug/mL IsoniazidcellWall

0.362

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.529

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.514

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.357

BZA0.12 mg/mL BenzamidearomaticAmides

0.247

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.018

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.006

H2O24 mM hydrogen peroxideDNAdamaging

-1.000

Levo10 ug/mL LevofloxacinDNAdamaging

-0.110

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.397

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.388

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.249

UVUV-irradiationDNAdamaging

-0.069

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.887

Antimycin12.5-50 ug/mL Antimycin A?

-1.209

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.250

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.517

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.186

PA8240.2-2 ug/mL PA-824?

0.765

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.175

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.136

Verapamil50 uM Verapamil?

-1.291

mercaptoethanol2 mM 2-Mercaptoethanol?

-2.004

methoxatin10-20 ug/mL Methoxatin?